Mp92-07 Netrin-1: A Novel Protein Identified in Disease Progression of Sunitinib Resistant Renal Cell Carcinoma

Journal of Urology- Netherlands

doi 10.1016/j.juro.2016.02.2640

Full Text

Abstract

Available in

Categories

Date

April 1, 2016

Authors

Sebastian Frees

Claudia Chavez-Munoz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Significance of Cyclooxygenase‑2, Prostaglandin E2 and CD133 Levels in Sunitinib‑resistant Renal Cell Carcinoma

Oncology Letters

Cancer Research

English

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology

English

Sphingosine Kinase 1 Overexpression Contributes to Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

English

A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma

Case Reports in Oncological Medicine

English

Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma

Molecular and Cellular Biology

Molecular Biology

English

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy

New England Journal of Medicine

English

Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma

Current Oncology

English

Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma

Acta Oncologica

Nuclear Medicine

English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer

English